Death-Associated Protein Kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1378-1383

  Brabender, Jan ^a   Arbab, Dariusch ^a   Huan, Xi ^a,c   Vallböhmer, Daniel ^a   Grimminger, Peter ^a   Ling, Frederike ^a   Neiss, Susanne ^a   Bollschweiler, Elfriede ^a   Schneider, Paul M ^b   Hölscher, Arnulf H ^a   Metzger, Ralf ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEATH ASSOCIATED PROTEIN KINASE; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; MALE; MUTATION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; METHYLATION; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; YOUNG ADULT;

EID: 64249166459     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0356-1     Document Type: Article

References (36)

1. CA Sherman AT Turrisi MB Wallace CE Reed 2002 Locally advanced esophageal cancer Curr Treat Options Oncol 3 475 85
2. TN Walsh N Noonan D Hollywood 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 7
3. SG Urba MB Orringer A Turrisi 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 13
4. DP Kelsen 2000 Multimodality therapy of esophageal cancer: an update Cancer J 6 Suppl 2 S177 81
5. K Schulmann A Sterian A Berki 2005 Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk Oncogene 24 4138 48
6. RL Momparler 2003 Cancer epigenetics Oncogene 22 6479 83
7. CA Eads RV Lord SK Kurumboor 2000 Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma Cancer Res 60 5021 6
8. CA Eads RV Lord K Wickramasinghe 2001 Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 61 3410 8
9. JP Hamilton F Sato Z Jin 2006 Reprimo methylation is a potential biomarker of Barrett's-associated esophageal neoplastic progression Clin Cancer Res 12 6637 42
10. MV Brock M Gou Y Akiyama 2003 Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clin Cancer Res 9 2912 9
11. K Kawakami J Brabender RV Lord 2000 Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma J Natl Cancer Inst 92 1805 11
12. JP Hamilton F Sato BD Greenwald 2006 Promoter methylation and response to chemotherapy and radiation in esophageal cancer Clin Gastroenterol Hepatol 4 701 8
13. JL Kissil E Feinstein O Cohen 1997 DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene Oncogene 15 403 7
14. KR Blank MS Rudoltz GD Kao 1997 The molecular regulation of apoptosis and implications for radiation oncology Int J Radiat Biol 71 455 66
15. SH Kaufmann WC Earnshaw 2000 Induction of apoptosis by cancer chemotherapy Exp Cell Res 256 42 9
16. L Milas V Gregoire N Hunter 1997 Radiation-induced apoptosis in tumors: effect of radiation modulating agents Adv Exp Med Biol 400B 559 64
17. PM Schneider SE Baldus R Metzger 2005 Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 684 92
18. JF Bosset M Gignoux JP Triboulet 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 161 7
19. E Bollschweiler W Schroder AH Holscher JR Siewert 2000 Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus Br J Surg 87 1106 10
20. A Olek J Oswald J Walter 1996 A modified and improved method for bisulphite based cytosine methylation analysis Nucleic Acids Res 24 5064 6
21. CA Eads KD Danenberg K Kawakami 1999 CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression Cancer Res 59 2302 6
22. J Brabender H Usadel R Metzger 2003 Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome Clin Cancer Res 9 223 7
23. J Brabender H Usadel KD Danenberg 2001 Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival Oncogene 20 3528 32
24. CE Metz DJ Goodenough K Rossmann 1973 Evaluation of receiver operating characteristic curve data in terms of information theory, with applications in radiography Radiology 109 297 303
25. R Miller D Siegmund 1982 Maximally selected chi-square statistics Biometrics 38 1011 6
26. J Halpern 1982 Maximally selected chi-square statistics for small samples Biometrics 38 1017 23
27. 2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity EMBO J 16 998 1008
28. X Tang FR Khuri JJ Lee 2000 Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer J Natl Cancer Inst 92 1511 6
29. D Vallbohmer J Brabender D Yang 2006 DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value Clin Lung Cancer 8 39 44
30. S Toyooka KO Toyooka K Miyajima 2003 Epigenetic down-regulation of death-associated protein kinase in lung cancers Clin Cancer Res 9 3034 41
31. FC Ling N Leimbach SE Baldus 2006 HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer Anticancer Res 26 4505 9
32. F Miyazono R Metzger U Warnecke-Eberz 2004 Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer Br J Cancer 91 666 72
33. U Warnecke-Eberz S Hokita H Xi 2005 Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer Oncol Rep 13 1241 6
34. U Warnecke-Eberz R Metzger F Miyazono 2004 High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer Clin Cancer Res 10 3794 9
35. H Xi SE Baldus U Warnecke-Eberz 2005 High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer Clin Cancer Res 11 8341 7
36. ML McCabe Z Dlamini 2005 The molecular mechanisms of oesophageal cancer Int Immunopharmacol 5 1113 30